Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy | Cancer Immunology Research
PLOS ONE: A Novel Approach for Characterizing Microsatellite Instability in Cancer Cells
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy - Gastroenterology
MSI-H Biomarker | Colorectal Cancer Alliance
Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor‑related genes in gastric cancer
Frontiers | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer | Oncology
Microsatellite Instability assessment in Black South African Colorectal Cancer patients reveal an increased incidence of suspected Lynch syndrome | Scientific Reports
Microsatellite instability in Gastric Cancer: Between lights and shadows - Cancer Treatment Reviews
Immunotherapy Combination Approved for Colorectal Cancer - National Cancer Institute
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes: Cell
Microsatellite Instability - Defective DNA Mismatch Repair
Presence of MSI-H, MMR-D Predicts Lynch Syndrome Across Tumor Types
A. Multi-region sequencing data for a MSI-high colorectal cancer from... | Download Scientific Diagram
JCM | Free Full-Text | Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review | HTML
MSI/MSS Colorectal Cancers - TRanslational ONCOlogy
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Microsatellite instability - Wikipedia
Both MSI and IHC -
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers | SpringerLink
Subtyping of microsatellite instability-high colorectal cancer | Cell Communication and Signaling | Full Text
Stomach and colorectal cancer: AI identifyies patients for immunotherapy • healthcare-in-europe.com
The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy | Cancer Discovery
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma - Cancer Treatment Reviews
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial† - Annals of Oncology
